Due to the COVID-19 pandemic, the scheduled shipping date of RH2020-02 and NS2020-02 survey has been changed.  The newly scheduled dates have been updated in each program website.

Preventive Medicine Foundation is a non-governmental, non-political and not-for-profit organization. It was established in 1987. We have provided External Quality Assurance ( EQA ) programs for clinical laboratories and newborn screening centers since 1988, including EQA programs for Glucose-6-Phosphate Dehydrogenase Deficiency ( G6PD ) quantitative test, G6PD screening test, and congenital hypothyroidism confirmatory tests. In addition to EQA programs, we started to provide G6PD Internal Quality Control ( IQC ) programs in 2008. More than 90 international newborn screening centers and clinical laboratories ( from 14 countries ) have participated in our EQA and/or IQC programs at present time.

We are the member of Clinical and Laboratory Standards Institute ( CLSI ) and European organisation for External Quality Assurance Providers in Laboratory Medicine ( EQALM ).

Accredited to ISO/IEC 17043

Lastest News

2019-10-28
Reports of EQA Survey
2019 4^th Run

for Neonatal G6PD Screening Test ( Survey No.：NS2019-04 )

for Neonatal G6PD Quantitative Test in Taiwan ( Survey No.：RH2019-04 )  (PDF_Chinese version)

for Neonatal G6PD Quantitative Test in Philippines ( Survey No.：RH2019-04 ) (PDF)

2019-01-01
2019 External Quality Assurance (EQA) Program for G6PD Quantitative Test in Philippines  [EQA Survey Schedule for 2019]

2019 External Quality Assurance (EQA) Program for Neonatal G6PD Screening Test [EQA Survey Schedule for 2019]